Phase IIa Study to Evaluate Daratumumab for Polyneuropathy Associated With MGUS
Latest Information Update: 30 May 2025
At a glance
- Drugs Daratumumab/hyaluronidase (Primary)
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- Acronyms Dara-MGUS
Most Recent Events
- 22 May 2025 Planned initiation date changed from 1 Apr 2025 to 1 Jul 2025.
- 24 Mar 2025 Planned initiation date changed from 1 Jan 2025 to 1 Apr 2025.
- 20 Dec 2024 Planned initiation date changed from 1 Dec 2024 to 1 Jan 2025.